These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37846515)

  • 1. Value of ctDNA methylation biomarkers in diagnosis of colorectal tumors.
    Shi YJ; Dong YH; Mei ZB; Wang H
    Epigenomics; 2023 Sep; 15(18):891-893. PubMed ID: 37846515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer.
    Zhang X; Hou H; Jiang M; Zhang X
    Mol Biol Rep; 2023 Mar; 50(3):2743-2750. PubMed ID: 36583782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures.
    Gouda MA; Duose DY; Lapin M; Zalles S; Huang HJ; Xi Y; Zheng X; Aldesoky AI; Alhanafy AM; Shehata MA; Wang J; Kopetz S; Meric-Bernstam F; Wistuba II; Luthra R; Janku F
    Oncologist; 2023 Apr; 28(4):368-372. PubMed ID: 36200910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
    Muthamilselvan S; Raghavendran A; Palaniappan A
    PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
    Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
    Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
    Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
    J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
    Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer.
    Lange CP; Campan M; Hinoue T; Schmitz RF; van der Meulen-de Jong AE; Slingerland H; Kok PJ; van Dijk CM; Weisenberger DJ; Shen H; Tollenaar RA; Laird PW
    PLoS One; 2012; 7(11):e50266. PubMed ID: 23209692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of specific hypermethylated WIF1 and NPY genes in circulating DNA by crystal digital PCR™ is a powerful new tool for colorectal cancer diagnosis and screening.
    Overs A; Flammang M; Hervouet E; Bermont L; Pretet JL; Christophe B; Selmani Z
    BMC Cancer; 2021 Oct; 21(1):1092. PubMed ID: 34627187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma.
    Fan J; Li J; Guo S; Tao C; Zhang H; Wang W; Zhang Y; Zhang D; Ding S; Zeng C
    Clin Epigenetics; 2020 Apr; 12(1):56. PubMed ID: 32317010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
    Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP
    Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation.
    Mo S; Ye L; Wang D; Han L; Zhou S; Wang H; Dai W; Wang Y; Luo W; Wang R; Xu Y; Cai S; Liu R; Wang Z; Cai G
    JAMA Oncol; 2023 Jun; 9(6):770-778. PubMed ID: 37079312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.
    Gyparaki MT; Basdra EK; Papavassiliou AG
    J Mol Med (Berl); 2013 Nov; 91(11):1249-56. PubMed ID: 24057814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook.
    Lianidou E
    Mol Oncol; 2021 Jun; 15(6):1683-1700. PubMed ID: 33942482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.
    Wang W; Zhu X; Zhang X; Lei C; Zeng Z; Lan X; Cui W; Wang F; Xu S; Zhou J; Wu X; Deng H; Li X; Fan J; Ding Y; Huang Z; Liang L
    J Pathol; 2023 Apr; 259(4):376-387. PubMed ID: 36573552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.